RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Lifecore Biomedical - Stock

Lifecore Biomedical Stocks 2024

Lifecore Biomedical Stocks

29.96 M

Ticker

LFCR

ISIN

US5147661046

WKN

899376

In 2024, Lifecore Biomedical had 29.96 M outstanding stocks, a 0% change from the 29.96 M stocks in the previous year.

The Lifecore Biomedical Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2026e29.96
2026e29.96
2025e29.96
2024e29.96
202329.96
202229.5
202129.3
202029.2
201928.6
201827.9
201727.7
201627
201527.3
201427.1
201326.6
201226.1
201126.6
201026.6
200926.8
200826.9
200726.6
200625.7
200524.6
200423.6

Lifecore Biomedical Aktienanalyse

What does Lifecore Biomedical do?

Landec Corp is a US-American company specialized in the development, manufacturing, and marketing of innovative products in the Agribusiness and Biotechnology sectors. It was founded in 1986 as a spin-off from the engineering faculty of Stanford University. The company follows a unique business model based on the integration of advanced technologies and biological processes. This aims to achieve sustainable agriculture that is both mindful of natural resources and achieves high yields. One of Landec's main divisions is the Fresh-Cut Products segment, where the company produces a variety of high-quality salads, vegetable, and fruit snacks that are distributed under the brand Eat Smart®. These products are known for their freshness, taste, and healthy nutritional values, and have gained high recognition in the USA. Another important business division of Landec is the Apio Packaging segment, specialized in the manufacturing and marketing of innovative packaging solutions for fresh fruits and vegetables. The packaging, distributed under the brand BreatheWay®, is equipped with a unique technology that regulates gas exchange within the package and extends the shelf life of the contents. In addition to these core segments, Landec is also active in the field of Biotechnology. Here, the company develops innovative products and technologies for use in human healthcare as well as the agricultural industry. An example of this is Apio's recently introduced whole plant juice called GreenWise™. Landec Corp is known for its innovation capabilities and its ability to develop new products and technologies. Throughout its history, the company has acquired a number of patents and awards and constantly strives to improve and advance its products. Overall, Landec Corp is a company that focuses on sustainability, innovation, and quality. With its unique business model and wide range of products and services, the company is well-positioned to continue growing and expanding its leadership position in the agriculture and biotechnology industry. Lifecore Biomedical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Lifecore Biomedical's Shares Outstanding

Lifecore Biomedical's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Lifecore Biomedical’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Lifecore Biomedical’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Lifecore Biomedical’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Lifecore Biomedical Stock

How many stocks are there of Lifecore Biomedical?

The current number of stocks of Lifecore Biomedical is 29.96 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Lifecore Biomedical are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Lifecore Biomedical evolved in recent years?

The number of shares of Lifecore Biomedical has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Lifecore Biomedical as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Lifecore Biomedical?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Lifecore Biomedical pay?

Over the past 12 months, Lifecore Biomedical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lifecore Biomedical is expected to pay a dividend of 0 USD.

What is the dividend yield of Lifecore Biomedical?

The current dividend yield of Lifecore Biomedical is .

When does Lifecore Biomedical pay dividends?

Lifecore Biomedical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lifecore Biomedical?

Lifecore Biomedical paid dividends every year for the past 0 years.

What is the dividend of Lifecore Biomedical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lifecore Biomedical located?

Lifecore Biomedical is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Lifecore Biomedical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lifecore Biomedical from 6/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/11/2024.

When did Lifecore Biomedical pay the last dividend?

The last dividend was paid out on 6/11/2024.

What was the dividend of Lifecore Biomedical in the year 2023?

In the year 2023, Lifecore Biomedical distributed 0 USD as dividends.

In which currency does Lifecore Biomedical pay out the dividend?

The dividends of Lifecore Biomedical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lifecore Biomedical

Our stock analysis for Lifecore Biomedical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lifecore Biomedical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.